These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10460607)

  • 1. Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction.
    Fontenay-Roupie M; Bouscary D; Guesnu M; Picard F; Melle J; Lacombe C; Gisselbrecht S; Mayeux P; Dreyfus F
    Br J Haematol; 1999 Aug; 106(2):464-73. PubMed ID: 10460607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
    Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
    Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.
    Backx B; Broeders L; Hoefsloot LH; Wognum B; Löwenberg B
    Leukemia; 1996 Mar; 10(3):466-72. PubMed ID: 8642863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes.
    Merchav S; Nielsen OJ; Rosenbaum H; Sharon R; Brenner B; Tatarsky I; Scigalla P; Wieczorek L
    Leukemia; 1990 Nov; 4(11):771-4. PubMed ID: 2232891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin-induced activation of STAT5 is impaired in the myelodysplastic syndrome.
    Hoefsloot LH; van Amelsvoort MP; Broeders LC; van der Plas DC; van Lom K; Hoogerbrugge H; Touw IP; Löwenberg B
    Blood; 1997 Mar; 89(5):1690-700. PubMed ID: 9057652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes.
    Verbeek W; Vehmeyer K; Wörmann B; Hiddemann W
    J Cancer Res Clin Oncol; 1995; 121(6):338-42. PubMed ID: 7797598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant negative effect of a truncated erythropoietin receptor (EPOR-T) on erythropoietin-induced erythroid differentiation: possible involvement of EPOR-T in ineffective erythropoiesis of myelodysplastic syndrome.
    Shimizu R; Komatsu N; Miura Y
    Exp Hematol; 1999 Feb; 27(2):229-33. PubMed ID: 10029161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis.
    Raimbault A; Pierre-Eugene C; Rouquette A; Deudon C; Willems L; Chapuis N; Mathis S; Kunz C; Fricke H; Kosmider O; Bardet V; Fontenay M;
    Oncotarget; 2016 Mar; 7(12):14898-911. PubMed ID: 26910909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired erythropoiesis after haemorrhagic shock in mice is associated with erythroid progenitor apoptosis in vivo.
    Robinson Y; Matenov A; Tschöke SK; Weimann A; Oberholzer A; Ertel W; Hostmann A
    Acta Anaesthesiol Scand; 2008 May; 52(5):605-13. PubMed ID: 18419713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.
    Sato T; Maekawa T; Watanabe S; Tsuji K; Nakahata T
    J Clin Invest; 2000 Jul; 106(2):263-70. PubMed ID: 10903342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Tumor Necrosis Factor-Alpha on Erythropoietin and Erythropoietin Receptor-Induced Erythroid Progenitor Cell Proliferation in β-Thalassemia/Hemoglobin E Patients.
    Tanyong DI; Panichob P; Kheansaard W; Fucharoen S
    Turk J Haematol; 2015 Dec; 32(4):304-10. PubMed ID: 26376749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPO receptor, Bax and Bcl-x(L) expressions in murine erythropoiesis after cyclophosphamide treatment.
    Juaristi JA; Aguirre MV; Todaro JS; Alvarez MA; Brandan NC
    Toxicology; 2007 Mar; 231(2-3):188-99. PubMed ID: 17254689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD.
    Claessens YE; Park S; Dubart-Kupperschmitt A; Mariot V; Garrido C; Chrétien S; Dreyfus F; Lacombe C; Mayeux P; Fontenay M
    Blood; 2005 May; 105(10):4035-42. PubMed ID: 15677568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor.
    Klingmüller U
    Eur J Biochem; 1997 Nov; 249(3):637-47. PubMed ID: 9395308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes.
    Bowen DT; Jacobs A; Cotes PM; Lewis TC
    Eur J Haematol; 1990 Jan; 44(1):30-2. PubMed ID: 2307217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
    Shi J; Yuan B; Hu W; Lodish H
    Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unregulated activation of STAT-5, ERK1/2 and c-Fos may contribute to the phenotypic transformation from myelodysplastic syndrome to acute leukaemia.
    Kolonics A; Apáti A; Nahajevszky S; Gáti R; Brózik A; Magócsi M
    Haematologia (Budap); 2001; 31(2):125-38. PubMed ID: 11583024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters.
    Bowen DT; Culligan D; Beguin Y; Kendall R; Willis N
    Leukemia; 1994 Jan; 8(1):151-5. PubMed ID: 8289479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guinea pig serum erythropoietin (EPO) selectively stimulates guinea pig erythroid progenitors: human or mouse erythroid progenitors do not form erythroid burst-forming unit colonies in response to guinea pig serum EPO.
    Stopka T; Zivny JH; Goldwasser E; Prchal JF; Necas E; Prchal JT
    Exp Hematol; 1998 Aug; 26(9):910-4. PubMed ID: 9694513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.